(22 May 2025)
RESTRICTION SUMMARY:
++MUSIC CLEARED FOR USE++
ASSOCIATED PRESS
ARCHIVE: Hillerod, Denmark – 26 September 2023
1. Shot of box of diabetes drug Ozempic at Novo Nordisk production facility
ASSOCIATED PRESS
New York – 20 May 2025
2. SOUNDBITE (English) Lucas Mavromatis, New York University:
"So the question we’re investigating in this study is whether the use of GLP-1 receptor agonists, which is a medication for weight loss and diabetes, is associated with a lower risk of obesity-associated cancers as compared to DPP-4 inhibitors, another medication for diabetes."
ASSOCIATED PRESS
ARCHIVE: Hillerod, Denmark – 26 September 2023
3. Various of diabetes drug Ozempic going through automated packaging line at Novo Nordisk production facility
ASSOCIATED PRESS
New York – 20 May 2025
4. SOUNDBITE (English) Lucas Mavromatis, New York University:
"So we found that people who take GLP-1 receptor agonists in our cohort of American patients have a lower incidence of obesity related cancers compared to those who take DPP-4 inhibitors."
ASSOCIATED PRESS
ARCHIVE: Front Royal, Virginia – 1 March 2024
5. STILL: Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home
ASSOCIATED PRESS
ARCHIVE: Hillerod, Denmark – 26 September 2023
6. Shot of box of diabetes drug Ozempic at Novo Nordisk production facility
ASSOCIATED PRESS
New York – 20 May 2025
7. SOUNDBITE (English) Lucas Mavromatis, New York University:
"I think reassuringly, we saw no increased risk of cancer with the GLP1 receptor agonists, which is important because they’re becoming prescribed more and more widely for more and more indications."
ASSOCIATED PRESS
ARCHIVE: St. Petersburg, Florida – 7 November 2023
8. Kelly Burns, tirzepatide clinical trial participant, cooks behind an injectable pen of tirzepatide
ASSOCIATED PRESS
ARCHIVE: Hillerod, Denmark – 26 September 2023
9. Various of diabetes drug Ozempic in packaging line
ASSOCIATED PRESS
Houston – 20 May 2025
10. SOUNDBITE (English) Dr. Ernest Hawk, MD Anderson Cancer Center:
"Ozempic is probably one of the best known for diabetes, and Wegovy would be another example."
ASSOCIATED PRESS
ARCHIVE: Temecula, California – 30 April 2024
11. STILL: Wegovy injectable pens
ASSOCIATED PRESS
Houston – 20 May 2025
12. SOUNDBITE (English) Dr. Ernest Hawk, MD Anderson Cancer Center:
"I don’t think this study has any implications for patients or for providers at this point, clinicians, because again, it’s demonstrating a possible association, but the effect is quite mild at a 7 to 8% reduction in risk of either incidence or all-cause mortality. And so really what this is is a call to scientists and clinical investigators to do more work in this area to really prove or disprove this association."
ASSOCIATED PRESS
ARCHIVE: Hillerod, Denmark – 26 September 2023
13. Shot of diabetes drug Ozempic in packaging line
ASSOCIATED PRESS
ARCHIVE: Front Royal, Virginia – 1 March 2024
14. STILL: Doses of Wegovy, a drug used for weight loss, are stored in a refrigerator
ASSOCIATED PRESS
ARCHIVE: Temecula, California – 30 April 2024
15. STILL: Stack of Wegovy boxes
STORYLINE:
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.
This type of study can’t prove cause and effect, but the findings hint at a connection worth exploring. More than a dozen cancers are associated with obesity.
AP produced by Javier Arciga
___
Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Twitter: https://twitter.com/AP_Archive
Facebook: https://www.facebook.com/APArchives
Instagram: https://www.instagram.com/APNews/
You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/1f7c6f32c56c4980b42e488a4ca31c1b
Author: AP Archive
Go to Source
News post in May 27, 2025, 9:05 pm.
Visit Our Sponsor’s:
News Post In – News
